Search research articles
Contact Us
Filters
Showing results (1-10 of 135) with videos related to
Page
of 14
Sort By:
Sub-Cellular Biochemistry
|
September 21, 2004
Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications
Yechezkel Barenholz
Nature Nanotechnology
|
August 7, 2012
Nanomedicine: Shake up the drug containers
Yechezkel Barenholz
Journal of Liposome Research
|
May 3, 2003
Relevancy of drug loading to liposomal formulation therapeutic efficacy
Yechezkel Barenholz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 10, 2012
Doxil®--the first FDA-approved nano-drug: lessons learned
Yechezkel Barenholz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 17, 2012
Liposomes and other assemblies as drugs and nano-drugs: from basic and translational research to the clinics
Yechezkel Barenholz, Dan Peer
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 28, 2015
In vitro experiments showing enhanced release of doxorubicin from Doxil® in the presence of ammonia may explain drug release at tumor site
Lisa Silverman, Yechezkel Barenholz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 6, 2010
Optimization of vincristine-topotecan combination--paving the way for improved chemotherapy regimens by nanoliposomes
Daniel Zucker, Yechezkel Barenholz
Analytical Biochemistry
|
November 18, 2005
pH determination by pyranine: medium-related artifacts and their correction
Yuval Avnir, Yechezkel Barenholz
Journal of Drug Targeting
|
October 30, 2016
Liposomal nano-drugs based on amphipathic weak acid steroid prodrugs for treatment of inflammatory diseases
Keren Turjeman, Yechezkel Barenholz
Methods in Enzymology
|
June 3, 2004
Use of nitroxides to protect liposomes against oxidative damage
Ayelet M Samuni, Yechezkel Barenholz
Page
of 14
Search research articles
Search
Showing results (1-10 of 135) with videos related to
Sort By:
Page
of 14
Sub-Cellular Biochemistry
|
September 21, 2004
Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications
Yechezkel Barenholz
Nature Nanotechnology
|
August 7, 2012
Nanomedicine: Shake up the drug containers
Yechezkel Barenholz
Journal of Liposome Research
|
May 3, 2003
Relevancy of drug loading to liposomal formulation therapeutic efficacy
Yechezkel Barenholz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 10, 2012
Doxil®--the first FDA-approved nano-drug: lessons learned
Yechezkel Barenholz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 17, 2012
Liposomes and other assemblies as drugs and nano-drugs: from basic and translational research to the clinics
Yechezkel Barenholz, Dan Peer
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 28, 2015
In vitro experiments showing enhanced release of doxorubicin from Doxil® in the presence of ammonia may explain drug release at tumor site
Lisa Silverman, Yechezkel Barenholz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 6, 2010
Optimization of vincristine-topotecan combination--paving the way for improved chemotherapy regimens by nanoliposomes
Daniel Zucker, Yechezkel Barenholz
Analytical Biochemistry
|
November 18, 2005
pH determination by pyranine: medium-related artifacts and their correction
Yuval Avnir, Yechezkel Barenholz
Journal of Drug Targeting
|
October 30, 2016
Liposomal nano-drugs based on amphipathic weak acid steroid prodrugs for treatment of inflammatory diseases
Keren Turjeman, Yechezkel Barenholz
Methods in Enzymology
|
June 3, 2004
Use of nitroxides to protect liposomes against oxidative damage
Ayelet M Samuni, Yechezkel Barenholz
Page
of 14